Business intelligence for the animal health industries
Animal Pharm Reports
Essential business, market and company information
Reports 2003

Immunodiagnostics and Nucleic Acid Testing Kits for the Veterinary Industry: Current status and future prospects
Published: 09/12/2003
Click here to view Chapter 1
 
The market for immunodiagnostics and nucleic acid testing (NAT) was worth $440 million in 2002 and is forecast to grow to $587 million by 2008, when companion animal products will account for two thirds of sales. This Animal Pharm report will provide you with essential technical, managerial and market information to improve your business performance.

World Animal Health Markets to 2010
Published 20/11/2003
Click here to view Chapter 1

In this report, the most authoritative available, we have profiled the animal health markets in 15 countries, accounting for more than 80% of the world market.

Generics in the Animal Health Industry: Threats and opportunities
Published: 07/11/2003
Click here to view Chapter 1

An analysis of all the key issues facing generic and R&D-focused animal health companies in one of the key commercial arenas of the next decade. Threats and opportunities will provide essential business information for managers in R&D-focused and generic companies on patent and product registration law, marketing, new product development and market dynamics.

Companion Animals: A new market for human pharmaceuticals and insecticides
Published: 09/07/2003
Click here to view Chapter 1

Current human pharmaceuticals and insecticides present some of the best opportunities for new products for companion animals. These 'crossover products' avoid long and costly development programmes and are likely to be the brands that will drive growth in the companion animal sector over the next decade. The report analyses all the technical and managerial issues in this key area and will help you to identify the next generation of products in the most dynamic sector of the global animal health industry.

Salmonella: Market opportunities for the animal health industry
Published:11/06/2003
Click here to view Chapter 1

Salmonella is a major issue for all stakeholders in the food chain. Its control represents a significant market for animal health companies that manufacture antimicrobials, vaccines and diagnostic tools. 423 million of Salmonella control products were sold in 2002, and this figure is forecast to rise to $669 million by 2007. The largest growth area will be vaccines, sales of which should see an eight-fold increase over the next five years. Salmonella: Market opportunities for the animal health industry analyses all aspects of this dynamic market, which is being driven by new product development and increasingly stringent legislation.

Animal Health Marketing Strategies in the EU
Published: 02/05/2003
Click here to view Chapter 1

A guide to the marketing and distribution of animal health products across 15 countries. The European animal health market is worth $3.3 billion, but each of the 15 national markets has its own structure, distribution routes, buying culture and regulatory environment. This represents 15 sets of challenges and opportunities

Licensing and Partnership Opportunities in Animal Health R&D
Published: 21/04/2003
Click here to view Chapter 1

Much of the most innovative R&D in the animal health industry is being done by specialist companies developing proprietary technologies. Licensing and Partnership Opportunities in Animal Health R&D provides detailed profiles of 22 companies that are developing the technologies that will drive growth in the animal health industry over the next decade - companies at the cutting edge of research in vaccines, biotechnology, oncology products, adjuvants, drug delivery and a host of other technologies and therapeutic areas.

R&D in the Animal Health and Nutrition Industry
Published: 07/02/2003
Click here to view Chapter 1

This report details the research and development that is being undertaken worldwide in the animal health and nutrition industry. It features an analysis of R&D by disease target, allowing you to identify the latest developments in any sector of commercial interest, and the institutions that are undertaking this work. The report includes a detailed analysis of the R&D being undertaken by the 20 largest animal health and nutrition companies, enabling you to investigate the threats posed by your competitors, and to predict the products that they have in their development pipeline.